IgY passive immunotherapy for pandemic preparedness: a One Health platform approach against pathogen X
Clinical Microbiology Reviews · 2026
DOI: 10.1128/cmr.00249-25 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Microbiology Reviews, 2026. Verfasst von Sherif A El-Kafrawy und 4 weiteren Autor:innen. Beteiligte Einrichtung: Special Infectious Agent Unit-BSL3, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia. Hauptthemen laut MEDLINE: Immunoglobulins, Immunization, Passive, Pandemics. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
The rising threat of emerging infectious diseases, especially zoonotic pathogens crossing species barriers, highlights the urgent global need for scalable, rapid-response passive immunotherapy platforms. Chicken egg yolk-derived immunoglobulin Y (IgY) antibodies offer unique conceptual and practical advantages. This review critically evaluates IgY antibodies (IgY-Abs) as a One Health immunotherapeutic strategy with strong potential for mitigating zoonotic spillover risks. Drawing on insights from SARS-CoV-2, we highlight the advantages of IgY-Abs over traditional approaches in specific scenarios while emphasizing their role as a complementary rather than replacement platform within the broader passive immunotherapy landscape. We discuss key strategic considerations, regulatory challenges, and essential knowledge gaps. Finally, we propose a forward-looking research and development roadmap that emphasizes interdisciplinary collaboration, optimized production methods, targeted regulatory frameworks, and integrated One Health strategies to facilitate the rapid deployment of IgY-based countermeasures against WHO-priority zoonotic pathogens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Special Infectious Agent Unit-BSL3, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.
- Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.
- Animal Facility Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.
- Faculty of Medicine, Menoufia University, Shebeen El-Kom, Egypt.
ORCID-Profile: Sherif A El-Kafrawy, Aymn T Abbas
Zitieren
APA
El-Kafrawy, S. A., Abbas, A. T., Abdel-Dayem, U. A., El-Kafrawy, M. S., & Azhar, E. I. (2026). IgY passive immunotherapy for pandemic preparedness: a One Health platform approach against pathogen X. Clinical Microbiology Reviews. https://doi.org/10.1128/cmr.00249-25
Vancouver
El-Kafrawy SA, Abbas AT, Abdel-Dayem UA, El-Kafrawy MS, Azhar EI. IgY passive immunotherapy for pandemic preparedness: a One Health platform approach against pathogen X. Clinical Microbiology Reviews. 2026. doi:10.1128/cmr.00249-25
BibTeX
@article{ElKafrawy2026,
author = {El-Kafrawy, Sherif A and Abbas, Aymn T and Abdel-Dayem, Umama A and El-Kafrawy, Menatalla S and Azhar, Esam I},
title = {IgY passive immunotherapy for pandemic preparedness: a One Health platform approach against pathogen X},
journal = {Clinical Microbiology Reviews},
year = {2026},
doi = {10.1128/cmr.00249-25}
}
EUVIMED